La biotecnología revoluciona la detección temprana del cáncer de próstata, cuya incidencia... 11/06/2024 Salud Acceso a la innovación Digitalización La biotecnología es fundamental en el diagnóstico, tratamiento y seguimiento del cáncer de próstata y desempeña un... AseBio
Biotechnology revolutionizes early detection of prostate cancer, the incidence of which co... 11/06/2024 Biotechnology is central to the diagnosis, treatment and follow-up of prostate cancer and plays a broad role across the... AseBio
Rafael Simó: "We should talk about "obesities" instead of "obesity" because more and more... 06/06/2024 Healthcare Access to innovation Drug discovery Geneis Biomed interviews Dr. Rafael Simón, head of the Endocrinology and Nutrition Department at Vall d'Hebron... Partners - GENESIS Biomed
Register for Webinar: Oligonucleotide Drugs: Key ADME & DMPK Insights 04/06/2024 Healthcare Pharmaron is holding a training webinar on June 20 on the importance of oligonucleotide drugs in modern medicine. Partners
Use of biotechnology in advanced therapies and new technologies in the spanish market 03/06/2024 Healthcare Access to innovation Advanced therapies Among the most important emerging technologies are the manipulation of the microbiota, CAR-T cell therapies, and gene... Partners - KONEXIO BIOTECH
Oryzon announces journal publication of final Phase IIa ALICE results with iadademstat in ... 03/06/2024 Healthcare Access to innovation Rare diseases Innovative drugs Advanced therapies The Phase IIa study ALICE evaluated the combination of iadademstat plus azacitidine in newly diagnosed, unfit patients... Partners - Oryzon Genomics
Oryzon to provide corporate progress updates at several events in June 30/05/2024 Healthcare Corporate BIO International Convention 2024. Congreso de la European Hematology Association (EHA) 2024. European Network to Cure... Partners - Oryzon Genomics
BCN HEALTH publishes a study estimating the cost of thalassaemia care across the world 29/05/2024 Healthcare Rare diseases BCN HEALTH desarrolló un modelo de costes aplicable a nivel mundial para la atención de la talasemia. Partners - BCN Health
Oryzon selected as Associated Partner in the first Important Project of Common European In... 29/05/2024 Healthcare Access to innovation Drug discovery Rare diseases Innovative drugs Personalized medicine Financing Commission has approved up to €1 billion of State aid by six Member States: Belgium, France, Hungary, Italy, Slovakia... Partners - Oryzon Genomics
